---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

secured: "DWVxjOK2bSRAN4RTcQPwlpl3LwLLhmosPfD7vOk1kxiX+QQqLpoRlHq7O6FDNmK+1Qyv11mq++9OWE0bp6RMIP29+w53i/MyrAkSVKNw4EsTGkvpOgB6/MI9q9Lkrd2+8b701DkR+A+vDpjXk8lpEBj98FrxY3j0HOUAM1vkw3ycqULeuIsLufuOpM1GoLwgK63XD/n99QMV3IUuInQGKTGxLJGmk3YUVrj6qiLxlvce3yUuzrS9O1Kqjvu/JrQIhoN206NywcK+o1JoUqURQE61U9bkTd5J6NJCRHZC0ftLbYnLTvp6EVbf4Q1gDQtw;l/FaYF5RNikD4zIFz9Tmug=="
---

